NCT07176416 Effective Phaco Time and Endothelial Cell Loss When Using Veritas
| NCT ID | NCT07176416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aloha Vision Consultants |
| Condition | Cataract |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-10-03 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-10-03 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
Eligibility Criteria
Inclusion Criteria: * Adult patients undergoing age-related cataract surgery. * Planned use of the Catalys Precision Laser System. * Planned implantation of TECNIS intraocular lenses (IOLs). Exclusion Criteria: • Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).
Contact & Investigator
Carlton Yuen, MD
PRINCIPAL INVESTIGATOR
Aloha Vision Consultants
Frequently Asked Questions
Who can join the NCT07176416 clinical trial?
This trial is open to participants of all sexes, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07176416 currently recruiting?
Yes, NCT07176416 is actively recruiting participants. Contact the research team at avc.alanad@gmail.com for enrollment information.
Where is the NCT07176416 trial being conducted?
This trial is being conducted at ‘Aiea, United States.
Who is sponsoring the NCT07176416 clinical trial?
NCT07176416 is sponsored by Aloha Vision Consultants. The principal investigator is Carlton Yuen, MD at Aloha Vision Consultants. The trial plans to enroll 50 participants.